11 ACCF/AHA focused update of the guideline
for the management of patients with peripheral artery disease
(updating the 2005 guideline): a report of the American College of
Cardiology Foundation/American Heart Association Task Force on
Practice Guidelines: developed in collaboration with the Society for
Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society for Vascular Medicine, and Society for
Vascular Surgery. J Vasc Surg 2011;54:e32-58.
52. Force USPST; U.S. Preventive Services Task Force. Screening for
peripheral arterial disease: recommendation statement. Am Fam
Physician 2006;73:497-500.
53. Fowkes FG, Housley E, Riemersma RA, Macintyre CC, Cawood EH,
Prescott RJ, et al. Smoking, lipids, glucose intolerance, and blood
pressure as risk factors for peripheral atherosclerosis compared with
ischemic heart disease in the Edinburgh Artery Study. Am J Epidemiol
1992;135:331-40.
54. Fowler B, Jamrozik K, Norman P, Allen Y, Wilkinson E. Improving
maximum walking distance in early peripheral arterial disease: randomised controlled trial. Aust J Physiother 2002;48:269-75.
55. Fowkes FG, Price JF, Stewart MC, Butcher I, Leng GC, Pell AC,
et al. Aspirin for prevention of cardiovascular events in a general
population screened for a low ankle brachial index: a randomized
controlled trial. JAMA 2010;303:841-8.
56. Heart Protection Study Collaborative Group. MRC/BHF Heart
Protection Study of cholesterol lowering with simvastatin in 20,536

JOURNAL OF VASCULAR SURGERY
Volume 61, Number 3S

high-risk individuals: a randomised placebo-controlled trial. Lancet
2002;360:7-22.
57. McDermott MM, Guralnik JM, Greenland P, Pearce WH,
Criqui MH, Liu K, et